2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Keratosis, Actinic
22
Cholangiocarcinoma
8
Carcinoma, Basal Cell
8
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Skin Neoplasms
4
Bile Duct Neoplasms
4
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lung Neoplasms
3
Liver Neoplasms
3
Leukoplakia, Oral
3
Colorectal Neoplasms
3
Warts
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Pleural Diseases
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Bowen's Disease
2
Basal Cell Nevus Syndrome
2
Barrett Esophagus
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Interventions
Gemcitabine
6
Cisplatin
6
Capecitabine
6
Liver Transplantation
4
Fluorouracil
4
Specimen Handling
3
Radiosurgery
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
toripalimab
2
dehydroftorafur
2
Self Expandable Metallic Stents
2
Platinum
2
Leucovorin
2
Biopsy
2
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
2
1,2-diaminocyclohexaneplatinum II citrate
2
trisacryl gelatin microspheres
1
tremelimumab
1
trametinib
1
tislelizumab
1
temoporfin
1
sacituzumab govitecan
1
ricolinostat
1
pembrolizumab
1
lenvatinib
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
durvalumab
1
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
Photochemotherapy
×
Clear all
NCT05551299
2025-03-27
CARP
University of Leipzig
Phase 4
Recruiting
258 enrolled